ACYCLOVIR Mepha cpr 200 mg 25 pce
7680536680117
CH-53668
J05AB01
08.03.0.
Reimbursement limitations:
HERPESSIMIM2
Usage uniquement en cas d'infection d'herpès simple chez le patient avec immunosuppression (p. ex. lors …
1 / 3
google
Details
- Product number
- 5366801
- CPT
- -
- Packaging group
- 25
- Unit
- Tablette(n)
- Composition
- aciclovirum 200 mg, lactosum monohydricum 203 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, silica colloidalis anhydrica, copovidonum, magnesii stearas, pro compresso corresp. natrium 0.84 mg.
Articles (1)
Acyclovir-Mepha 200, Tabletten
Tabletten
25
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
203.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.84 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 28.20
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
15/03/1997
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 53668
- Drug name
- Acyclovir-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- J05AB01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/02/1997
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ACYCLOVIR Mepha cpr 200 mg 25 pce
- Description (DE)
- ACYCLOVIR Mepha Tabl 200 mg 25 Stk
- Market launch
- 25/02/1997
- Narcotic (BTM)
- No